FDA Will Be Given Cost-Effectiveness Role, Acting Commissioner Predicts
Executive Summary
Congress is likely to consider expanding FDA's mission to include direct consideration of economic factors in making approval decisions, Acting Commissioner Lester Crawford, PhD, predicted